Tag: Pediatric

  • JAKs could be future of pediatric alopecia treatment

    JAKs could be future of pediatric alopecia treatment

    January 26, 2023

    1 min read through

    Source:

    Friedlander S, et al. Pediatric Dermatology 2023. Presented at: Maui Derm Jan. 23-27, 2023 Wailea, Hawaii.

    Disclosures:
    Healio could not confirm fiscal disclosures at the time of publication.


    We have been unable to system your request. Please attempt once more later. If you continue on to have this situation please get hold of [email protected].

    WAILEA, Hawaii — Janus kinase inhibitors could be the foreseeable future of alopecia areata remedy in children if analysis proves them to be safer than existing warnings counsel, according to a presenter at the Maui Derm conference.

    “This disproportionately has an effect on youngsters. … It arrives on early in existence and results in a lot of challenges in the childhood a long time,” Sheila Friedlander, MD, professor emeritus at UC San Diego College of Drugs and a pediatric skin doctor at Scripps Clinic San Diego, said in the course of her presentation. “When I stroll into a space and a individual has [alopecia areata], I sigh simply because I know there is no straightforward respond to and I also know that this sickness that people today say is beauty is not a beauty condition. This is a deforming illness.”

    Woman holds hairbrush containing hair lost to alopecia.
    Janus kinase inhibitors could be the potential of alopecia areata cure in young children if investigation proves them to be safer than current warnings counsel.

    Janus kinase (JAK) inhibitors ruxolitinib, baracitinib and tofacitinib, as properly as the tyrosine kinase 2 inhibitor deucravacitinib, in possibly oral or the much more possible topical formulation, could be valuable for these patients however, all JAK inhibitors presently carry a boxed warning for important adverse cardiovascular situations.

    No topical or systemic JAK inhibitor is currently accredited for alopecia areata in youngsters having said that, baracitinib is authorized for the sign in older people and has been examined in juvenile people with other disorders.

    Ruxolitinib is accepted for atopic dermatitis remedy in children aged at the very least 12 years, and oral tofacitinib is authorized for juvenile idiopathic arthritis in small children aged more mature than 2 yrs. There are also scientific studies being performed for deucravacitinib in the pediatric alopecia inhabitants.

    “I consider JAK inhibitors are genuinely to the rescue for alopecia and far more information is being gathered,” Friedlander stated. “I’m not telling you to place all your little ones on oral JAKs, but I want you to notice the relevance they perform.”

    The security profile of JAK inhibitors is the primary caveat to their use in children, and that is anything of which to be conscious, Friedlander added.

    The use of topicals, as lengthy as the right car is remaining utilized, is a single possibility where the threats could be much less than with oral medications.

    Moreover, retaining an open up brain to option treatment options could be beneficial for clients since there is no Food and drug administration-authorised drug for this indicator.

    “When a loved ones comes in with this sort of trouble, never right away discard these things,” Friedlander said. “There’s some details out there indicating it may be handy.”

  • There’s a shortage of pediatric antibiotic medicines

    There’s a shortage of pediatric antibiotic medicines

    With many households throughout the place dealing with ill young children, the desire for reduction is high. But now, these shortages are extending to spot hospitals.

    WASHINGTON — It is a common sight at quite a few D.C. spot pharmacies: vacant shelves of several pediatric cough and flu reduction items. Medical practitioners say the return to normalcy write-up-pandemic is primary to a rebound of the two viral and bacterial infections that dipped in current yrs. 

    With quite a few family members across the place dealing with unwell youngsters, the demand for reduction is substantial. But now, these shortages are extending to area hospitals.

    But now, these shortages are extending to location hospitals.

    “Principal treatment doctors are truly overwhelmed with the quantity of prescriptions that they are making use of to take care of our small children,” claimed Kid’s National Clinic VP Main Pharmacy officer Dr. Eric Balmir. “Parents should not fear. There are different medications readily available and your child will still be treated appropriately for their ailment.”

    In accordance to pediatricians, several of the shortages are prescription-only antibiotics like oseltamivir or Tamiflu. 

    “Despite the fact that we are beginning to see some shortages in fever reducer medications, like acetaminophen, which is Tylenol and ibuprofen, which is Motrin, and Advil,” Annapolis-centered pediatrician Dr. Christina Johns claimed. 

    Montgomery County Govt Mark Elrich resolved what he phone calls the “Tri-demic” of COVID-19, RSV, and the seasonal flu. 

    “The hospitals are truly anxious about capacity levels and we have a few issues out there that can put persons in the hospitals,” Elrich said. 

    https://www.youtube.com/check out?v=TdRyDT3c-lY

    The trigger, according to medical practitioners WUSA9 talked to: Drug manufacturers base orders on forecasts from before in the yr, which did not predict a spike in RSV. Little ones contaminated with viruses could later want antibiotics mainly because of secondary infections.

    As for individuals neighborhood pharmacies encountering shortages of around the counter medicines, Dr. Johns suggests home remedies may perform ideal for straightforward coughs:

    “There is no good proof that any over the counter medicine performs properly in kids, so what we suggest in pediatrics is for kids who are over 12 months old to merely do a teaspoon of honey every few of hrs,” Johns reported. “And that helps to coat the inside of of the throat which can then aid to give maximize the all round humidity in the airway. That can actually assist settle down the cough. For children more youthful than 12 months that is not advisable. And so it’s only a make any difference of sitting down and enjoying in the lavatory with the steam likely entire tilt in the shower with your younger little one to assistance to reduce the cough. But in common, we propose averting those cough medications.”

    Maryland released their RSV monitoring on the internet dashboard Wednesday. The spike in instances appears to be coming down.

    WUSA9 is now on Roku and Amazon Fireplace TVs. Down load the applications nowadays for live newscasts and online video on demand from customers.

    Download the WUSA9 app to get breaking information, climate and essential tales at your fingertips.

    Sign up for the Get Up DC e-newsletter: Your forecast. Your commute. Your information.
    Sign up for the Capitol Breach email newsletter, delivering the most recent breaking news and a roundup of the investigation into the Capitol Riots on January 6, 2021.

  • How common is pediatric cannabis use and what are the risks?

    How common is pediatric cannabis use and what are the risks?

    A current study published in the Journal of the American School of Crisis Physicians (JACEP) Open evaluated the current use of marijuana and its spinoff products, their results and clinical manifestations, perceptions, pharmaceutics, epidemiological studies, and the very long-time period ramifications in pediatric populations.

    How common is pediatric cannabis use and what are the risks?
    Analyze: Cannabis use in small children: An update focusing on pediatric tetrahydrocannabinol and cannabidiol use. Picture Credit score: Yarygin/Shutterstock

    Background             

    Hashish is among the the most well-known recreational medicines in the United States (US), and an raising quantity of young children and adolescents consume it in some sort. The legalization of cannabis has triggered a spike in the drug’s use among the children and young adults, owing to the common understanding of the projected negligible danger with its use. 

    On the other hand, hashish use in the course of childhood poses dangers of acute intoxication because of to overdose and permanent neuropsychiatric improvements. Also, hazards connected with serious intestinal absorption are not unusual with hashish use through childhood.

    Pharmacology of Hashish

    Cannabinoids are ingredients that bring about the euphoric and sedative outcomes of cannabis, as they bind to specific brain receptors. Cannabidiol (CBD) and delta-9 tetrahydrocannabinol (THC) are the two extensively investigated and perfectly-acknowledged cannabinoids having said that above 100 kinds of cannabinoids are at the moment regarded.

    CBD is an thoroughly utilised cannabinoid spinoff and it does not interact with THC receptors or possess any psychoactive outcomes. CBD is recognised for its analgesic, anti-nausea, anxiolytic, anti-inflammatory antipsychotic, anti-epileptic, and anti-ischemic outcomes.

    THC impacts the hypothalamus, cerebellum, and hippocampus, to elicit psychotropic results and sensations. Concentrations of THC in the serum improve in minutes of usage, reaching a peak inside 1-4 hrs, and thereafter, quickly drop.

    There are various varieties of Hashish Cannabis refers to dried and crushed leaves/flowers the concentrated oil is recognized as ‘hash oil’ while the resin component is recognised as hashish. Even more, digital vapor and other hashish solutions have amplified the drug’s accessibility and performance.

    Marijuana legalization has significantly increased availability and accessibility, primarily amongst the more youthful era. A 2019, National Study of Drug Use and Wellbeing depicted that proportion of people over the age of 12 decades who applied cannabis escalated from 25.8 million in 2002 to 48.2 million in 2019 – with the number of adolescents who started off using marijuana in the former calendar year averaging all around 3,700 adolescents per working day.

    Cannabidiol

    Right up until June 30, 2021, poison handle institutes experienced now dealt with 2,158 cannabidiol circumstances. Utah documented 52 incidents of CBD oil poisoning for the duration of 2017 and 2018, with signs or symptoms which includes hallucinations, nausea/vomiting, seizures, and decline of consciousness. 

    Despite the fact that there have been instances of unintended adulteration of these products with THC, the medical overall look of acute CBD intoxication is ordinarily benign. Quite a few aspect effects of cannabidiol are gastrointestinal (nausea, emesis, diarrhea). On top of that, there is been grievances of respiratory distress and psychogenic consequences.

    In adults, cannabinoids may perhaps help modulate chemotherapy-induced nausea and vomiting. Having said that, none of these scientific studies proof effective Cannabis use in young children. In the meantime, specific retrospective or observational research and case stories depict the efficacy of cannabinoids in halting recalcitrant seizures.

    Significant, randomized, controlled scientific studies investigating the efficacy of pharmaceutical-quality cannabidiol (CBD) in pediatric sufferers with Dravet and Lennox-Gastaut syndromes uncovered similar efficacy to typical anticonvulsants. The Food items and Drug Administration (Food and drug administration) has permitted the use of a CBD treatment for each Dravet and Lennox-Gastaut syndromes, on the other hand, the system continues to be uncertain. 

    In up to 15{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of the clients, cannabidiol has been affiliated with adverse results these types of as nausea, seizures, and improves in serum alanine aminotransferase and aspartate aminotransferase. In more instances, hyperammonemia and serious thrombocytopenia ended up documented. All of these aspect consequences appeared to be dose-dependent. 

    Handling these adverse results involves the withdrawal of CBD medicine. Having said that, the lengthy-term effects of CBD intake stay uncertain. In addition, pharmaceutical formulations might be topic to inconsistent regulation.

    Delta-9-tetrahydrocannabinol (THC)

    Observation exposed situations of THC incidence and acute overdose. From 2004 to 2014, it was noted that little ones more youthful than 3 yrs of age ended up admitted to a pediatric unexpected emergency area due to accidental publicity to hashish. Ten of the 29 admitted infants analyzed good for cannabis in their urine and necessary acute care. Among the these, 87{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of instances of intoxication happened at residence. Resin was the most frequent kind of ingested cannabis. In addition, based on the kind ingested, the scientific visual appeal of a client with acute THC intoxication can differ. 

    Pure THC in edible products can have significantly different damaging results than uncooked cannabis. Immediately after acute consumption, the most typically reported signs and symptoms in kids are depression, disorientation, agitation, ataxia, lethargy, and coma. Dexmedetomidine was established to be a relatively risk-free and successful procedure for juvenile cannabis or normal cannabinoid exposures , to help in taking care of acute THC toxicity.

    Various systemic and psychological penalties have been connected to persistent cannabis use. The most common and significant facet consequences are – cannabinoid hyperemesis dysfunction, central nervous technique-relevant facet effects, cardiorespiratory repercussions, and a larger chance of bodily harm. Even though hashish use for the duration of being pregnant has been linked to newborn neurodevelopmental difficulties and autism spectrum disorders.

    When it comes to withdrawal syndrome remedy, no analyze on cannabis has been posted. However in the remedy of withdrawal signs and symptoms behavioral procedure and many pharmacologic prescription drugs, for instance – dronabinol, nabiximols, gabapentin, specific sedatives, and hypnotics may possibly be utilized. 

    Considering that its legalization, cannabis acceptability and use have greater, as the drug has garnered a standing for risk-free use or lack of unwell effects. Even so, solid parental vigilance is crucial, together with peer discouraging all over cannabis use, which may help in averting hashish use between pediatric age teams.

    Conclusion

    This evaluate summarizes the present investigation on cannabis use in kids, including incidence, the quick-time period and extensive-time period aspect results, and widespread utilization. Legalization appears to be to have contributed to the projected ‘safety’ of cannabis. Nevertheless, the threats linger. The hazards associated with marijuana use amongst kids could establish deleterious, and the potential for lasting neuropsychiatric troubles involves prompt motion and propagation of preventive recognition.

  • VIVO Cannabis(TM) Announces Launch of Beacon Medical(TM) High-Dose CBD Oil and Pediatric Compassionate Care Program

    VIVO Cannabis(TM) Announces Launch of Beacon Medical(TM) High-Dose CBD Oil and Pediatric Compassionate Care Program


    Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.


    Toronto, Ontario–(Newsfile Corp. – November 23, 2021) – VIVO Cannabis Inc. (TSX: VIVO)(OTCQX: VVCIF) (“VIVO” or the “Company“), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”) and ABcann Medicinals Inc., today announced the launch of its newest medical cannabis product formulation: high-dose cannabidiol (CBD) oil under its Beacon Medical” brand.

    Beacon Medical” 2:100 high-dose CBD oil is a distillate-based cannabis oil containing 100 mg CBD and less than 2 mg tetrahydrocannabinol (THC). The entire family of Beacon Medical” oil products are formulated using a non-GMO, food-grade medium-chain triglycerides (MCT) carrier oil which results in the final product being both scentless and flavourless in taste.

    “With our commitment to the medical cannabis market, the team at VIVO aspires to deliver premium cannabinoid-based medical products to our patients, and the Beacon Medical” CBD+ | O has been launched in response to patient insights our team has collected over time,” commented Ray Laflamme, Canna Farms’ Co-Founder and VIVO’s Chief Executive Officer. “We recognize that many of our patients are looking for products that meet their individualized needs, and this latest addition to the Beacon Medical family of products is an excellent high potency CBD option for patients and it will be available to patients, doctors, and hospitals alike.”

    Cannot view this image? Visit: https://orders.newsfilecorp.com/files/3063/104861_d6d7d616944e29cd_002.jpg

    Beacon CBD +|O [2:100] Extra-strength CBD oil to help patients achieve their health objectives

    To view an enhanced version of this graphic, please visit:
    https://orders.newsfilecorp.com/files/3063/104861_d6d7d616944e29cd_002full.jpg

    VIVO simultaneously announced the launch of a Pediatric Compassionate Care Program to support caregivers and families requiring medical cannabis to treat a variety of pediatric conditions. Eligible patients will receive substantial discounts off all Beacon Medical”, Canna Farms”, Fireside” and Lumina” CBD products.

    VIVO stands strong on its patient-first approach ensuring choice, access, and consistent supply for patients. Beacon Medical” products are available exclusively in select medical markets in Canada, Australia & Germany.

    This newly launched Beacon Medical” high CBD oil is available through the Canna Farms e-commerce medical marketplace for Canadian medical clients. Patients requiring support with registration or placing orders can contact VIVO’s Customer Care Team at 1 (855) 882-0988 or [email protected].

    About VIVO Cannabis”

    VIVO Cannabis” is recognized for trusted, premium cannabis products and services. It holds production and sales licences from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities. VIVO has a collection of medical, health and wellness brands, each targeting different customer segments, including Canna Farms”, Beacon Medical”, Fireside”, and Lumina”. Harvest Medicine”, VIVO’s patient-centric, scalable network of medical cannabis clinics, has serviced over 150,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. For more information visit: www.vivocannabis.com.

    For further information:

    VIVO Investor Relations
    +1 416-848-9839
    [email protected]

    Instagram: https://www.instagram.com/vivo_cannabis/
    Facebook: https://www.facebook.com/vivocanna/
    Twitter: https://twitter.com/vivo_cannabis
    LinkedIn: https://www.linkedin.com/company/vivo-cannabis-inc/

    Disclaimer for Forward-Looking Information

    Certain statements in this news release are forward-looking statements, which are statements that are not purely historical, including statements regarding the beliefs, plans, expectations or intentions of VIVO and its management regarding the future. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forwardlooking statements. No assurance can be given that any of the events anticipated by the forwardlooking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully along with the more extensive risk factors included in the Company’s most recent management’s discussion and analysis available on SEDAR, in evaluating the forwardlooking statements contained in this news release and are cautioned not to place undue reliance on such forwardlooking statements, which are qualified in their entirety by these cautionary statements. The forwardlooking statements in this news release are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any such forwardlooking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.

    To view the source version of this press release, please visit https://www.newsfilecorp.com/release/104861

  • Pediatric COVID-19 vaccinations underway in Chippewa County

    Pediatric COVID-19 vaccinations underway in Chippewa County

    CHIPPEWA FALLS, Wis. (WEAU) – Angela Weideman, Director and Health Official at the Chippewa County Department of Public Health, is providing an update on COVID-19 cases, vaccines, and testing during the health department’s COVID-19 situation report on Thursday. You can watch it here.

    Of the 316 active COVID-19 cases, 25.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} are children (81), including 23.1{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of all cases being school-aged children ages 4 to 18. 17 people are currently hospitalized in Chippewa County with COVID-19. More metrics are available on the Chippewa County COVID-19 data dashboard. The Chippewa County COVID-19 dashboard was experiencing technical difficulties during the update Thursday morning, but a full accounting of the metrics that were scheduled to be shared are below (updated Thursday afternoon).

    Chippewa County’s COVID-19 caseload and spread places the county in the severe risk category for COVID-19, which means the recommendation from the county’s health department is to limit indoor gatherings to less than 15 people and outdoor gatherings to less than 50 people with physical distancing. Masks are also recommended indoors, including at K-12 schools. As of Wednesday, the Wisconsin Department of Health Services says that Chippewa County is experiencing very high COVID-19 case activity with a case burden of over 781 cases per 100,000 residents. The Centers for Disease Control and Prevention has Chippewa County in the highest category for COVID-19 transmission, high, along with nearly every other county in Wisconsin.

    In Chippewa County, 34,560 residents have received at least one dose of COVID-19 vaccine, or 53.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, as of Nov. 5. 33,271 residents, or 51.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, have completed their vaccination series. 255 COVID-19 vaccine doses were administered to Chippewa County residents the last full week reporting numbers were available, Oct. 24. 86.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of Chippewa County residents ages 65 and over are fully-vaccinated.

    Weideman shared that pediatric vaccinations “are doing well” based on feedback from community partners. Statewide and Chippewa County data dashboards were down Thursday morning, so Weideman was unable to provide exact numbers. No community clinics are planned for children ages 5 to 11 since the county does not provide the Pfizer vaccine. However, community partners are providing the Pfizer vaccine, and Weideman said that because the Pfizer vaccine is being provided in the county already, the health department doesn’t need to add it to their offerings for vaccines.

    A community testing site for COVID-19 is available at Jacob’s Well Church at 3211 North 50th Ave. in Lake Hallie. The site offers drive-thru PCR tests and is open on Mondays from 1 p.m. to 6 p.m. and Thursdays through Saturdays from 11 a.m. to 4 p.m. To register online, visit the COVID Connect website. Registration is also available on-site.

    Chippewa County holds weekly COVID-19 vaccination clinics at the court house on Thursdays from 8:30 a.m. to 3 p.m. This clinic offers both the Moderna and Johnson & Johnson vaccines, which are currently authorized for emergency use for people ages 18 and over. The Pfizer vaccine is not offered by the Chippewa County DPH at its clinics. If an individual wants to receive the Pfizer vaccine, which is also authorized for emergency use for people ages 12 to 15 and fully approved for people ages 16 and over, they can call the Chippewa County Department of Public Health at 715-492-3096 or visit the DPH’s COVID-19 Response Hub to find other vaccinators in the county in order to find a Pfizer vaccine. Anyone under the age of 18 will need parental consent to schedule and receive a vaccine.

    For parents looking for pediatric COVID-19 vaccines for children ages 5 to 11, they are urged to contact their health care provider.

    CDC data dashboards are available on the CDC data tracker website. The DHS also has a COVID-19 data dashboard for Wisconsin on their website. More COVID-19 information for Chippewa County can be found on the CCDPH website.

    Due to data issues Thursday morning, information about cases, deaths, hospitalizations and vaccines wasn’t able to be shared during the live update. Those figures are below.

    Case Summary (as of November 11, 2021)

    Wisconsin:

    • 816,427 Wisconsin residents have had positive test results (confirmed cases) for COVID-19.
    • The state’s current positive 7-day average is 2,453 cases.
    • A total of 8,688 Wisconsin residents have died from COVID-19.

    Chippewa County:

    • 11,028 people have had positive test results (confirmed cases). Of those 11,028 cases,
    • 317 people (236 adults, 81 children) are active cases.
    • School-aged children (4-18) account for 73 cases and children ages 0-3 account for 8 cases
    • Children currently make up 25.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of all active cases.
    • The county’s current positive 7-day average is 23 cases.
    • A total of 484 county residents have ever been hospitalized as a result of COVID-19.
    • 17 residents, all adults, are currently hospitalized as a result of COVID-19.
    • Sadly, a total of 119 county residents (111 not fully vaccinated, 8 fully vaccinated) have died from COVID-19.

    In the Northwest Region, currently:

    • 84{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of all hospital beds are in use (16{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} are available)
    • 93{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of ICU (intensive care unit) beds are in use (7{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} are available)
    • 15{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of ventilators are in use (85{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} are available)

    Testing Update

    From October 31-Nov 6, 549 total COVID-19 tests were completed and 238 people had positive COVID-19 test results. The previous week, October 24-30, we had 184 positive cases and 466 tests were completed.

    Vaccine Update

    As of Friday, November 5, 65,716 doses of vaccine have been administered to Chippewa County residents.

    • 34,560 Chippewa County residents have received at least one dose of the vaccine which is 53.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of the population.
    • 33,271 residents have completed the vaccine series accounting for 51.5{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of the population.
    • The week of 10/31, a total of 131 doses were administered to Chippewa County Of those doses, 115 were administered to adults.

    Copyright 2021 WEAU. All rights reserved.